Polypharmacy May Be the Cause of Acute Lithium Intoxication at the Second Day of Treatment

2Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

UNLABELLED: Lithium is frequently used as a mood stabilizer in patients with mood disorders. Lithium has a narrow therapeutic index and high toxicity. Predisposing factors for intoxication are advanced age, diet disturbances, comorbid medical conditions affecting heart, kidneys or central nervous system and polypharmacy. CASE REPORT: Here we present a case of a 74-year-old woman with a history of Parkinson's disease, hypertension and bipolar disorder. She was using quetiapine, valsartan with hydrochlorothiazide and levodopa with carbidopa. She presented with altered mental status and muscle rigidity. The patient was admitted with acute lithium intoxication after her second dose of treatment. Blood lithium level increased to 3.58 mEq/L. The woman was hospitalized in the Internal Medicine Intensive Care Unit. With hydration, her symptoms resolved and her lithium level returned to normal after 118 hours. CONCLUSIONS: Prescribing physicians and emergency room physicians should be aware of conditions which may cause a decreased threshold for intoxication.

Cite

CITATION STYLE

APA

Tursun, I., Tazegul, G., Karhan, O., Gunes, N., Ulukal, E., Atcakarlar, M. A. rpali, … Coban, E. (2015). Polypharmacy May Be the Cause of Acute Lithium Intoxication at the Second Day of Treatment. Folia Medica, 57(3–4), 261–263. https://doi.org/10.1515/folmed-2015-0048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free